Latest News
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem
/PRNewswire/ -- A news report from Yicai Global: On September 17, the BioShanghai Week 2026 opened at Zhangjiang Science Hall in Shanghai. Themed "AI for
Huawei presenta la nuova versione di Stellar AI Network per offrire al mondo dell'IA agentica una connettività intelligente e sicura
/PRNewswire/ -- In occasione di HUAWEI CONNECT 2026, Huawei ha presentato la nuova versione della soluzione Stellar AI Network, sviluppata secondo il principio
Huawei onthult het verbeterde Stellar AI-netwerk om de Agentische wereld te voorzien van veilige, intelligente connectiviteit
/PRNewswire/ -- Tijdens HUAWEI CONNECT 2026 onthulde Huawei zijn geüpgradede Stellar AI Network Solution onder de filosofie van veilige, intelligente
Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
/PRNewswire/ -- HUAWEI CONNECT 2026 kicked off in Shanghai, The HUAWEI AIDC Facility Summit was held alongside the event. Huawei unveiled its grid-interactive
Royal Bank of Canada Highlights 18% ROE, HSBC Synergies and U.S. Growth
Royal Bank Of Canada NYSE: RY Chief Financial Officer Katherine Gibson said the bank has made progress toward the strategic and financial objectives outlined at its Investor Day, citing growth across
WestBow Press Announces the Book, People of His Presence, Has Earned Exclusive Lighthouse Recognition
/PRNewswire/ -- WestBow Press announced today that People of His Presence by Benjamin Brown has qualified for the Lighthouse Recognition Program, an exclusive
PAPI: Differentiated Approach And Monthly Pay
The Parametric Equity Premium Income ETF offers a diversified, equal-weighted sector approach with a 7.55% TTM yield and monthly distributions. PAPI's differentiated strategy outperformed peers during
Alona Shevtsova Joins Payments Innovation Panel at MEBIS 2026 in Dubai
Sends CEO Alona Shevtsova joined senior banking and payments executives at the Middle East Banking Innovation Summit to discuss the
IXN: Massive Multiple Compression In Tech YoY, Too Cheap Today
I reiterate a buy rating on iShares Global Tech ETF after a 34% gain and significant multiple compression. IXN now trades at a high-teens P/E, with a compelling 28.5% long-term EPS growth rate and inc
DUO POWER BOOST: Clivet Debuts Next-Gen Magnetic Levitation Technology and AI Cooling Portfolio at AI Infra Summit 2026
/PRNewswire/ -- Under the DUO POWER BOOST theme, Clivet made the global debut of its Next-Gen Magnetic Levitation Technology at AI Infra Summit 2026 in Santa
SentinelOne's Land-And-Expand Strategy Is Driving Growth Across Every Product Line
SentinelOne is reaffirmed as a BUY, driven by robust AI-native cybersecurity solutions and strong land-and-expand execution. S1 demonstrates 21% YoY revenue growth and expanding ARR, with multiproduct
Rockwell Automation Sees Data Centers, Labor Crunch Fueling Automation Demand
Rockwell Automation NYSE: ROK executives said customer sentiment remains broadly positive despite inflation, tariffs and trade-policy uncertainty, with manufacturers continuing to prioritize productiv
BDC Weekly Review: Bond Issuance Remains An Income Headwind
We take a look at the action in business development companies through the second week of September and highlight some of the key themes we are watching. BDCs declined amid rising yields, Fed rate hik
When 210 million people learn Chinese, they see more than a language
/PRNewswire/ -- The following article was published today by China Daily. In the past, it was widely agreed that Chinese was difficult to learn. Today,
Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target
Incyte NASDAQ: INCY executives outlined a strategy centered on expanding its non-JAKAFI business, advancing a broader late-stage pipeline and preparing for the loss of exclusivity for JAKAFI after 202
Alnylam's Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial
Alnylam Pharmaceuticals NASDAQ: ALNY outlined its strategy for advancing zilebesiran, an investigational RNA interference, or RNAi, therapy designed to provide sustained blood-pressure control with tw
Mark Ruffalo leads Hollywood revolt against Paramount-Warner merger deal
He's calling on Bay Area supporters to show up outside Bonta's office, claiming he was hearing the AG was “about to cave”
Brookfield Asset Management Targets Doubling Fee-Bearing Capital by 2031
Brookfield Asset Management NYSE: BAM used its 2026 Investor Day to outline plans to double fee-bearing capital by 2031, supported by fundraising across flagship funds, complementary strategies, insur
Definium Therapeutics' DT120 Hits Phase III Goals in Anxiety Study
Definium Therapeutics NASDAQ: DFTX reported positive top-line results from Panorama, its second Phase III study of DT120 ODT 100 mcgs in generalized anxiety disorder, or GAD. The company said the sing
Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds
Cardinal Health NYSE: CAH CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what